期刊文献+

某院2010~2012年抗高血压药的应用分析

Analysis of Utilization of Antihypertensive Drugs in A Hospital During the Period 2010~2012
下载PDF
导出
摘要 目的了解我院抗高血压药的利用情况与趋势。方法对我院2010至2012年抗高血压药的种类、销售金额、用药频度等进行统计、分析。结果我院抗高血压药的销售金额呈逐年上升趋势。钙通道阻滞剂在三年中始终排在销售金额第一位,其次是血管紧张素Ⅱ受体阻滞剂和血管紧张素转换酶抑制剂。结论我院抗高血压药以钙通道阻滞剂、血管紧张素Ⅱ受体阻滞剂、血管紧张素转换酶抑制剂、β受体阻滞剂和利尿药为主,与国内外用药基本相符。钙通道阻滞剂、血管紧张素Ⅱ受体阻滞剂、血管紧张素转换酶抑制剂有广阔的用药前景。 Objeetive To investigate the current situation and development trend of antihypertensive drugs in our hospital. Methods The use of antihypertensive drugs in our hospital during the period 2010-2012 was analyzed retrospectively in terms of drug varieties, consumption sum, DDDs etc. Results The consumption sum of the antthypertensive drugs in our hospital increased year by year. The calcium channel blockers dominates the first place in annual consumption sum over the three years, followed by angiotensin I receptor antagonists and angiotensin converting enzyme inhibitors. Conclusion Calcium channel blockers, angiotensin II receptor antagonists, angiotensin converting enzyme inhibitors, beta recepteor blockers and diuretics were the dominant kinds among all the antihypertensive drugs used in our hospital, which is basically in line with the medication situation both at home and abroad. The application of calcium channel blockers, angiotensin I receptor antagonists and angiotensin converting enzyme inlaibitors has a broad prospect.
出处 《中国医药指南》 2013年第15期55-56,共2页 Guide of China Medicine
关键词 抗高血压药 销售金额 用药频度 用药分析 Antihypertensive drugs Consumption sum DDDs Drug utilization analysis
  • 引文网络
  • 相关文献

参考文献4

二级参考文献26

  • 1王宏宇 龚兰生 张维忠.血管紧张素Ⅱ受体1拮抗剂对高血压患者大动脉扩张性的影响[J].国际心血管杂志,1999,1(4):299-299.
  • 2Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomized trial: the Losurtan Heart Failure Survival Study. ELITE Ⅱ[J]. Lancet, 2000,255 : 1582-1587.
  • 3Konstam MA, Patten RD, Thomas I, et al. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure:results of the ELITE 'ventricular function substudy[J]. Am Heart J,2000, 139: 1081-1087.
  • 4Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[J]. N Engl J Med, 2001,345 : 1667-1675.
  • 5Malendowicz SL, Ennezat PV, Testa M, et al. Angiotensin Ⅱ receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure[ J]. Circulation, 2000, 102:2210-2213.
  • 6Timermans PB, Wong PC, Chiu AT, et al. Angiotensin Ⅱ receptors and angiotensin Ⅱ receptor antagonists [ J ]. Pharmacol Rev, 1993,45 : 205-251.
  • 7Bauer JH, Reams GP. The angiotensin Ⅱ type 1 receptor antagonists. A new class of antihypertensive drugs[J]. Arch Intem Med, 1995, 155:1361-1368.
  • 8Timmermans PB, Benfield P, Chiu AT, et al. Angiotensin Ⅱ receptors and functional correlates[ J]. Am J Hypertens, 1992,5 (Suppl) : 211 S-235S.
  • 9Urate H, Strobel F, Ganten D. Widespread tissue distribution of human chymase[ J]. J Hypertens, 1994,12(Suppl) : S17-S22.
  • 10Oparil S, Barr E, Elkins M, et al. Efficacy, tolerability, and effects on quality of lithe of losartan,alone or with hydro-chlorothiazide, in patients with essential hypertension[ J]. Clin Ther, 1996, 18:608-625.

共引文献886

;
使用帮助 返回顶部